Pharmacogenomics (PGx) Market Size to Reach USD 11.63 Billion by 2028 at CAGR 7.0% – The Brainy Insights
Nexstim Plc to license technology to US-based medical technology company Magnus Medical Inc. for the treatment of neuropsychiatric disorders